{"id":"mepyramine","rwe":[{"pmid":"41458489","year":"2025","title":"Mepyramine targets mutant Nav1.7 channels to relieve pain and erythema in primary erythromelalgia patients.","finding":"","journal":"Frontiers in medicine","studyType":"Clinical Study"},{"pmid":"41038295","year":"2025","title":"Recombinant IL-1β induces striatal dopamine depletion in aged rats: Involvement of histamine H(1) receptors.","finding":"","journal":"Brain research","studyType":"Clinical Study"},{"pmid":"30000145","year":"2006","title":"Pyrilamine.","finding":"","journal":"","studyType":"Clinical Study"},{"pmid":"40311833","year":"2025","title":"Neuroregulation of histamine of circadian rhythm disorder induced by chronic intermittent hypoxia.","finding":"","journal":"European journal of pharmacology","studyType":"Clinical Study"},{"pmid":"40079181","year":"2025","title":"A well-defined phosphine-free metal-ligand cooperative route for N-alkylation of aromatic amines via activation of renewable alcohols catalyzed by NNN pincer cobalt(II) complexes.","finding":"","journal":"Dalton transactions (Cambridge, England : 2003)","studyType":"Clinical Study"}],"_fda":{"id":"47dc39ad-82e8-6501-e063-6394a90ad52f","set_id":"45478958-ad86-4d87-e063-6394a90a3c45","openfda":{"nui":["N0000175739","N0000175729","N0000175790","M0023046"],"unii":["362O9ITL9D","3G6A5W338E","R35D29L3ZA"],"route":["ORAL"],"rxcui":["701913"],"spl_id":["47dc39ad-82e8-6501-e063-6394a90ad52f"],"brand_name":["Acetaminophen , Caffeine and pyrilamine maleate"],"spl_set_id":["45478958-ad86-4d87-e063-6394a90a3c45"],"package_ndc":["35916-0710-1"],"product_ndc":["35916-0710"],"generic_name":["ACETAMINOPHEN , CAFFEINE AND PYRILAMINE MALEATE"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Xanthines [CS]"],"pharm_class_pe":["Central Nervous System Stimulation [PE]"],"substance_name":["ACETAMINOPHEN","CAFFEINE","PYRILAMINE MALEATE"],"pharm_class_epc":["Central Nervous System Stimulant [EPC]","Methylxanthine [EPC]"],"manufacturer_name":["Softgel Healthcare Pvt Ltd"],"application_number":["M013"],"is_original_packager":[true]},"purpose":["purpose Pain reliever Diuretic Antihistamine"],"version":"2","stop_use":["Stop use and ask a doctor if • new symptoms occur • redness or swelling is present • pain gets worse or lasts more than 10 days • fever gets worse or lasts more than 3 days"],"warnings":["Warnings Liver warning : This product contains acetaminophen. Severe liver damage may occur if you take • more than 6 softgel in 24 hours, which is the maximum daily amount for this product • with other drugs containing acetaminophen • 3 or more alcoholic drinks every day while using this product Allergy alert: Acetaminophen may cause severe skin or severe allergic reactions. Symptoms may include: • hives • blisters • rash • skin reddening • facial swelling • asthma (wheezing) • shock If a skin or general allergic reaction occurs, stop use and seek medical help right away."],"ask_doctor":["Ask a doctor before use if you have • liver disease • glaucoma • difficulty in urination due to enlargement of the prostate gland • a breathing problem such as emphysema or chronic bronchitis"],"do_not_use":["Do not use • with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist • if you have ever had an allergic reaction to this product or any of its ingredients"],"when_using":["When using this product • you may get drowsy • avoid alcoholic drinks • excitability may occur, especially in children • alcohol, sedatives, and tranquilizers may increase drowsiness • be careful when driving a motor vehicle or operating machinery • limit the use of caffeine-containing medications, foods, or beverages beacuse too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat. The recommended dose of this product contains about as much caffeine as a cup of coffee."],"effective_time":"20260108","active_ingredient":["Active ingredient (in each softgelatin capsule) Acetaminophen 500mg Caffeine 60mg Pyrilamine maleate 15mg"],"inactive_ingredient":["Inactive ingredients croscarmellose sodium, D&C red 33 aluminum lake, edible black printing ink, ethyl cellulose, FD&C blue 1 aluminum lake, gelatin, glycerin, hydroxypropyl methylcellulose, isopropyl alcohol, magnesium stearate, microcrystalline cellulose, pregelatinized potato starch, purified water, PVPK-30, sorbitol sorbitan solution, talc, titanium dioxide, triacetin."],"indications_and_usage":["Uses for the temporary relief of these symptoms associated with menstural periods: • cramps • bloating • waterweight gain • headache • backache • muscle aches • fatigue"],"ask_doctor_or_pharmacist":["Ask a doctor or pharmacist before use if you are • taking the blood thinning drug warfarin • taking sedatives or tranquilizers"],"other_safety_information":["store at room temperature."],"dosage_and_administration":["Directions • do not take more than the recommended dose • adults and children 12 years and older: take 2 softgel with water • repeat every 6 hours as needed • do not exceed 6 softgel per day • children under 12 years: consult a doctor"],"spl_product_data_elements":["Acetaminophen , Caffeine and pyrilamine maleate Acetaminophen , Caffeine and pyrilamine maleate CROSCARMELLOSE SODIUM WATER ISOPROPYL ALCOHOL MICROCRYSTALLINE CELLULOSE D&C RED NO. 33 ALUMINUM LAKE STARCH, POTATO CAFFEINE CAFFEINE PYRILAMINE MALEATE PYRILAMINE GELATIN, UNSPECIFIED GLYCERIN ETHYLCELLULOSE, UNSPECIFIED HYPROMELLOSE, UNSPECIFIED ACETAMINOPHEN ACETAMINOPHEN TITANIUM DIOXIDE SORBITOL SORBITAN TALC TRIACETIN MAGNESIUM STEARATE POVIDONE K30 FD&C BLUE NO. 1 ALUMINUM LAKE Dark blue and light blue"],"pregnancy_or_breast_feeding":["If pregnant or breast-feeding, ask a health professional before use"],"keep_out_of_reach_of_children":["Keep out of reach of children. Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as children even if you do not notice any signs or symptoms."],"package_label_principal_display_panel":["bulk label"]},"tags":[{"label":"mepyramine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Histamine H1 receptor","category":"target"},{"label":"HRH1","category":"gene"},{"label":"ADORA3","category":"gene"},{"label":"SLC6A4","category":"gene"},{"label":"D04AA02","category":"atc"},{"label":"Oral","category":"route"},{"label":"Capsule","category":"form"},{"label":"Liquid","category":"form"},{"label":"Solution","category":"form"},{"label":"Syrup","category":"form"},{"label":"Active","category":"status"},{"label":"Allergic conjunctivitis","category":"indication"},{"label":"Allergic rhinitis","category":"indication"},{"label":"Common cold","category":"indication"},{"label":"Dermatographic urticaria","category":"indication"},{"label":"Dysmenorrhea","category":"indication"},{"label":"Influenza-like symptoms","category":"indication"},{"label":"Impax Labs","category":"company"},{"label":"Approved 1970s","category":"decade"},{"label":"Anti-Allergic Agents","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Central Nervous System Depressants","category":"pharmacology"},{"label":"Histamine Agents","category":"pharmacology"},{"label":"Histamine Antagonists","category":"pharmacology"},{"label":"Histamine H1 Antagonists","category":"pharmacology"},{"label":"Hypnotics and Sedatives","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"},{"label":"Sleep Aids, Pharmaceutical","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"llr":46.37,"date":"","count":10,"signal":"Total lung capacity decreased","source":"DrugCentral FAERS","actionTaken":"Reported 10 times (LLR=46)"},{"llr":41.203,"date":"","count":9,"signal":"Bronchopulmonary aspergillosis allergic","source":"DrugCentral FAERS","actionTaken":"Reported 9 times (LLR=41)"},{"llr":40.427,"date":"","count":10,"signal":"Lung opacity","source":"DrugCentral FAERS","actionTaken":"Reported 10 times (LLR=40)"},{"llr":32.975,"date":"","count":13,"signal":"Pulmonary mass","source":"DrugCentral FAERS","actionTaken":"Reported 13 times (LLR=33)"},{"llr":32.87,"date":"","count":10,"signal":"Blood calcium increased","source":"DrugCentral FAERS","actionTaken":"Reported 10 times (LLR=33)"}],"commonSideEffects":[],"contraindications":["Acidosis","Acute abdominal pain","Acute exacerbation of asthma","Acute hepatitis","Acute nephropathy","Acute pancreatitis","Agoraphobia","Alcohol intoxication","Alcohol withdrawal delirium","Alcoholism","Angle-closure glaucoma","Arterial thrombosis","Arteriosclerotic vascular disease","Asthenia","Benign intracranial hypertension","Benign prostatic hyperplasia","Bladder outflow obstruction","Bradycardia","Breastfeeding (mother)","Central nervous system depression","Chronic disease of respiratory system","Chronic heart failure","Chronic idiopathic constipation","Chronic obstructive lung disease","Coma"]},"trials":[],"aliases":[],"company":"Impax Labs","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=mepyramine","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:12:49.062264+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:12:56.541952+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=mepyramine","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:12:58.051462+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:12:46.836165+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:12:46.836199+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:12:46.836207+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL511/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:12:58.560677+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M013","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:12:46.836212+00:00"}},"allNames":"pyrilamine","offLabel":[],"synonyms":["pyrilamine","pyrilamine maleate","pyranisamine","mepyramine"],"timeline":[{"date":"1973-08-07","type":"positive","source":"DrugCentral","milestone":"FDA approval (Impax Labs)"}],"approvals":[{"date":"1973-08-07","orphan":false,"company":"IMPAX LABS","regulator":"FDA"}],"brandName":"Pyrilamine","ecosystem":[{"indication":"Allergic conjunctivitis","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alcaftadine","slug":"alcaftadine","company":"Allergan"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":null},{"indication":"Allergic rhinitis","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"astemizole","slug":"astemizole","company":""}],"globalPrevalence":null},{"indication":"Common cold","otherDrugs":[{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"azatadine","slug":"azatadine","company":""}],"globalPrevalence":null},{"indication":"Dermatographic urticaria","otherDrugs":[{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"azatadine","slug":"azatadine","company":""},{"name":"brompheniramine","slug":"brompheniramine","company":""}],"globalPrevalence":68000000},{"indication":"Dysmenorrhea","otherDrugs":[{"name":"caffeine","slug":"caffeine","company":"Novartis"},{"name":"celecoxib","slug":"celecoxib","company":"Gd Searle"},{"name":"diclofenac","slug":"diclofenac","company":""},{"name":"dienogest","slug":"dienogest","company":""}],"globalPrevalence":700000000},{"indication":"Influenza-like symptoms","otherDrugs":[{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"brompheniramine","slug":"brompheniramine","company":""},{"name":"caffeine","slug":"caffeine","company":"Novartis"},{"name":"chlorphenamine","slug":"chlorphenamine","company":"Bayer Healthcare Llc"}],"globalPrevalence":null},{"indication":"Itching of skin","otherDrugs":[{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"allantoin","slug":"allantoin","company":""},{"name":"ammonium lactate","slug":"ammonium-lactate","company":"Ranbaxy"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":null},{"indication":"Nasal congestion","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":null}],"mechanism":{"target":"Histamine H1 receptor","novelty":"Follow-on","targets":[{"gene":"HRH1","source":"DrugCentral","target":"Histamine H1 receptor","protein":"Histamine H1 receptor"},{"gene":"ADORA3","source":"DrugCentral","target":"Adenosine receptor A3","protein":"Adenosine receptor A3"},{"gene":"SLC6A4","source":"DrugCentral","target":"Sodium-dependent serotonin transporter","protein":"Sodium-dependent serotonin transporter"},{"gene":"CYP2D6","source":"DrugCentral","target":"Cytochrome P450 2D6","protein":"Cytochrome P450 2D6"},{"gene":"HTR2C","source":"DrugCentral","target":"5-hydroxytryptamine receptor 2C","protein":"5-hydroxytryptamine receptor 2C"},{"gene":"SIGMAR1","source":"DrugCentral","target":"Sigma non-opioid intracellular receptor 1","protein":"Sigma non-opioid intracellular receptor 1"},{"gene":"SLC6A3","source":"DrugCentral","target":"Sodium-dependent dopamine transporter","protein":"Sodium-dependent dopamine transporter"},{"gene":"KCNH2","source":"DrugCentral","target":"Potassium voltage-gated channel subfamily H member 2","protein":"Potassium voltage-gated channel subfamily H member 2"},{"gene":"ADRA2A","source":"DrugCentral","target":"Alpha-2A adrenergic receptor","protein":"Alpha-2A adrenergic receptor"},{"gene":"HTR2B","source":"DrugCentral","target":"5-hydroxytryptamine receptor 2B","protein":"5-hydroxytryptamine receptor 2B"}],"modality":"Small Molecule","drugClass":"Central Nervous System Stimulant [EPC]","explanation":"","oneSentence":"","technicalDetail":"Pyrilamine acts as a competitive antagonist at the histamine H1 receptor, binding to the receptor and preventing histamine from binding and activating the receptor, thereby reducing the allergic response."},"commercial":{"launchDate":"1973","_launchSource":"DrugCentral (FDA 1973-08-07, IMPAX LABS)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2331","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=mepyramine","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=mepyramine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:35:36.219262","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:13:01.298072+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"tripelennamine","drugSlug":"tripelennamine","fdaApproval":"1948-02-19","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"promethazine","drugSlug":"promethazine","fdaApproval":"1951-03-29","genericCount":48,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"clemastine","drugSlug":"clemastine","fdaApproval":"1977-02-25","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"pheniramine","drugSlug":"pheniramine","fdaApproval":"1994-06-08","relationship":"same-class"},{"drugName":"diphenhydramine","drugSlug":"diphenhydramine","fdaApproval":"1946-03-04","genericCount":56,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"mepyramine","indications":{"approved":[{"name":"Allergic conjunctivitis","source":"DrugCentral","snomedId":473460002,"regulator":"FDA","eligibility":"adults and children 6 years and older"},{"name":"Allergic rhinitis","source":"DrugCentral","snomedId":61582004,"regulator":"FDA","eligibility":"adults and children 6 years and older"},{"name":"Common cold","source":"DrugCentral","snomedId":82272006,"regulator":"FDA","eligibility":"no specific eligibility criteria mentioned"},{"name":"Dermatographic urticaria","source":"DrugCentral","snomedId":7632005,"regulator":"FDA","eligibility":"no specific eligibility criteria mentioned","usPrevalence":null,"globalPrevalence":68000000,"prevalenceMethod":"curated","prevalenceSource":"Allergy, 2020 (PMID:31494963)"},{"name":"Dysmenorrhea","source":"DrugCentral","snomedId":266599000,"regulator":"FDA","eligibility":"no specific eligibility criteria mentioned","usPrevalence":null,"globalPrevalence":700000000,"prevalenceMethod":"curated","prevalenceSource":"Cochrane, 2023"},{"name":"Influenza-like symptoms","source":"DrugCentral","snomedId":315642008,"regulator":"FDA","eligibility":"no specific eligibility criteria mentioned"},{"name":"Itching of skin","source":"DrugCentral","snomedId":418363000,"regulator":"FDA","eligibility":"no specific eligibility criteria mentioned"},{"name":"Nasal congestion","source":"DrugCentral","snomedId":68235000,"regulator":"FDA","eligibility":"no specific eligibility criteria mentioned"},{"name":"Nasal discharge","source":"DrugCentral","snomedId":64531003,"regulator":"FDA","eligibility":"no specific eligibility criteria mentioned","usPrevalence":null,"globalPrevalence":30000000,"prevalenceMethod":"curated","prevalenceSource":"Influenza Other Respir Viruses, 2023 (PMID:36824394)"},{"name":"Seasonal allergic rhinitis","source":"DrugCentral","snomedId":367498001,"regulator":"FDA","eligibility":"adults and children 6 years and older"},{"name":"Sinus headache","source":"DrugCentral","snomedId":4969004,"regulator":"FDA"},{"name":"Sneezing","source":"DrugCentral","snomedId":76067001,"regulator":"FDA"},{"name":"Urticaria","source":"DrugCentral","snomedId":126485001,"regulator":"FDA","usPrevalence":null,"globalPrevalence":68000000,"prevalenceMethod":"curated","prevalenceSource":"Allergy, 2020 (PMID:31494963)"},{"name":"Vasomotor rhinitis","source":"DrugCentral","snomedId":8229003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"tripelennamine","brandName":"tripelennamine","genericName":"tripelennamine","approvalYear":"1948","relationship":"same-class"},{"drugId":"promethazine","brandName":"promethazine","genericName":"promethazine","approvalYear":"1951","relationship":"same-class"},{"drugId":"clemastine","brandName":"clemastine","genericName":"clemastine","approvalYear":"1977","relationship":"same-class"},{"drugId":"pheniramine","brandName":"pheniramine","genericName":"pheniramine","approvalYear":"1994","relationship":"same-class"},{"drugId":"diphenhydramine","brandName":"diphenhydramine","genericName":"diphenhydramine","approvalYear":"1946","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT06312254","phase":"NA","title":"Pharmacological Modulation of Peripheral Nerve Excitability","status":"COMPLETED","sponsor":"Aalborg University","startDate":"2024-04-09","conditions":["Peripheral Neuropathy"],"enrollment":20,"completionDate":"2024-12-11"},{"nctId":"NCT02601235","phase":"PHASE3","title":"Efficacy and Safety of Pediatric Drugs in Nasal Congestion","status":"COMPLETED","sponsor":"EMS","startDate":"2018-01-16","conditions":["Nasal Congestion"],"enrollment":292,"completionDate":"2019-04-03"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Capsule, Liquid, Solution, Syrup","formulations":[{"form":"CAPSULE","route":"ORAL","productName":"Syncol"},{"form":"CAPSULE","route":"ORAL","productName":"Leader Premenstrual"},{"form":"LIQUID","route":"ORAL","productName":"Capron DM"},{"form":"LIQUID","route":"ORAL","productName":"Childrens PediaClear 8"},{"form":"LIQUID","route":"ORAL","productName":"Dayclear Allergy Relief"},{"form":"LIQUID","route":"ORAL","productName":"Kroger Allergy Relief"},{"form":"LIQUID","route":"ORAL","productName":"Ninjacof Cotton Candy Flavor- 16 oz"},{"form":"LIQUID","route":"ORAL","productName":"Ninjacof-A"},{"form":"LIQUID","route":"ORAL","productName":"Ninjacof-D"},{"form":"LIQUID","route":"ORAL","productName":"PRO-CHLO"},{"form":"LIQUID","route":"ORAL","productName":"TEXACLEAR FAST ACTING ALLERGY RELIEF"},{"form":"LIQUID","route":"ORAL","productName":"TexaClear Kids Allergy"},{"form":"LIQUID","route":"ORAL","productName":"Texaclear Fast Acting Allergy Relief"},{"form":"SOLUTION","route":"ORAL","productName":"Ninjacof"},{"form":"SYRUP","route":"ORAL","productName":"Glen PE"}]},"crossReferences":{"NUI":"N0000148008","MMSL":"4998","NDDF":"003377","UNII":"HPE317O9TL","VUID":"4019923","CHEBI":"CHEBI:6762","VANDF":"4018202","INN_ID":"106","RXNORM":"82091","UMLSCUI":"C0034282","chemblId":"CHEMBL511","ChEMBL_ID":"CHEMBL511","KEGG_DRUG":"D05660","DRUGBANK_ID":"DB06691","PUBCHEM_CID":"4992","SNOMEDCT_US":"349962001","IUPHAR_LIGAND_ID":"1227","SECONDARY_CAS_RN":"59-33-6","MESH_DESCRIPTOR_UI":"D011738"},"formularyStatus":[],"originalProduct":{"form":"TABLET, FILM COATED","route":"ORAL","company":"Time Cap Labs, Inc","brandName":"Comfort-Time","isOriginal":true,"marketingStatus":"OTC monograph not final"},"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1973-","companyName":"Impax Labs","relationship":"Original Developer"}],"publicationCount":1843,"therapeuticAreas":["Immunology"],"atcClassification":{"source":"DrugCentral","atcCode":"D04AA02","allCodes":["D04AA02","R06AC01"]},"biosimilarFilings":[],"originalDeveloper":"Impax Labs","recentPublications":[{"date":"2025","pmid":"41458489","title":"Mepyramine targets mutant Nav1.7 channels to relieve pain and erythema in primary erythromelalgia patients.","journal":"Frontiers in medicine"},{"date":"2025 Nov 15","pmid":"41038295","title":"Recombinant IL-1β induces striatal dopamine depletion in aged rats: Involvement of histamine H(1) receptors.","journal":"Brain research"},{"date":"2006","pmid":"30000145","title":"Pyrilamine.","journal":""},{"date":"2025 Jul 15","pmid":"40311833","title":"Neuroregulation of histamine of circadian rhythm disorder induced by chronic intermittent hypoxia.","journal":"European journal of pharmacology"},{"date":"2025 Apr 1","pmid":"40079181","title":"A well-defined phosphine-free metal-ligand cooperative route for N-alkylation of aromatic amines via activation of renewable alcohols catalyzed by NNN pincer cobalt(II) complexes.","journal":"Dalton transactions (Cambridge, England : 2003)"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Impax Labs","companyId":"impax-labs","modality":"Small Molecule","firstApprovalDate":"1973","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1973-08-07T00:00:00.000Z","mah":"IMPAX LABS","brand_name_local":null,"application_number":""},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":"1973-08-07T00:00:00.000Z","mah":"IMPAX LABS","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":"1973-08-07T00:00:00.000Z","mah":"IMPAX LABS","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":"1973-08-07T00:00:00.000Z","mah":"IMPAX LABS","brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":"1973-08-07T00:00:00.000Z","mah":"IMPAX LABS","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":"1973-08-07T00:00:00.000Z","mah":"IMPAX LABS","brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:13:01.298072+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}